Troy Tompkins - Concepedia

Author

Troy Tompkins

BioMarin (United States)

Also Known As

T. Tompkins, Troy Tompkins

Publications

668

Citations

H-Index

Concepts

All Affiliations

BioMarin (United States)Beth Israel Deaconess Medical Center Harvard University Massachusetts General Hospital

About

Troy Tompkins is an author at BioMarin (United States) specializing in autoimmunity, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	151
2	Immunology	4	4	151
3	Allergy	2	2	72
4	Cell Biology	1	1	28
5	Medical Laboratory Science	1	1	17

Troy Tompkins

Publications

658

Citations

H-Index

Page 1

	Year	Citations
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab Yiping Chen, Evelyn Bord, Troy Tompkins, New England Journal of Medicine	2009	209
Determinants of survival in progressive multifocal leukoencephalopathy Angela Marzocchetti, Troy Tompkins, David B. Clifford, Neurology	2009	166
Frequency and Phenotype of JC Virus-Specific CD8<sup>+</sup>T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy Marco Antônio Lima, Angela Marzocchetti, Patrick Autissier, Journal of Virology	2007	58
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial Becky Schweighardt, Troy Tompkins, Kelly Lau, Clinical Therapeutics Elosulfase AlfaAutoimmune DiseaseAllergyEnzyme Replacement TherapyImmunodeficiencies	2014	55
Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy Angela Marzocchetti, Christian Wüthrich, Chen Sabrina Tan, Journal of NeuroVirology RheumatologyMolecular VirologyAutoimmune DiseaseImmunologyViral Pathogenesis	2008	51
Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome Yulan Qi, Donald G. Musson, Becky Schweighardt, Clinical Pharmacokinetics	2014	40
Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study Brian Long, Troy Tompkins, Celeste Decker, Clinical Therapeutics	2016	34
Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy Angela Marzocchetti, Marco Antônio Lima, Troy Tompkins, Virology Autoimmune DiseaseMedicineImmunologyAntiviral ResponseAutoimmunity	2008	28
Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome Andrew C. Melton, Russell K. Soon, Troy Tompkins, Journal of Immunological Methods Immunocytochemical TechniqueImmunologyPathologyImmunophenotypingImmunotherapy	2016	17

Page 1